V

Vakona AB

4 employees

Vakona develops a new antibiotic-free treatment for inflammatory acne a natural bacterial enzyme that degrades the bacterial biofilm.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Acne vulgaris
Therapeutics
Pharmaceutical
Skincare
Biopharmaceuticals

Date founded

2020

Funding rounds raised

V

Vakona AB raised undisclosed on November 8, 2021

Investors: Stockholms Affärsänglar - STOAF and Partnerinvest Norr

V

Vakona AB raised undisclosed on January 1, 2021

Investors: Almi Invest

FAQ